Cat. No. Name Size Price Add Cart
KI0834Tacrolimus50 mg$144
Tacrolimus100 mg$272
Tacrolimus500 mg$688

Chemical Characteristic

Product NameTacrolimus
SynonymsFK 506, prograf, Advagraf, Protopic
CAS No.104987-11-3
Molecular Weight 804.02
FormulaC44H69NO12
Chemical Structure

Biological activities

Tacrolimus is a potent immunosuppressive drug. Tacrolimus is also a carbocyclic lactone-lactan isolated from Streptomycetes tsukubaensis. Tacrolimus is used as an immunosuppressant in transplantation medicine and immunological diseases. Tacrolimus ultimately blocks the T-cell response by inhibiting IL-2 transcription. Tacrolimus profoundly affects the maturation process of human epidermal Langerhans' cells.[1] Tacrolimus is also an inhibitor of IL-2 promoter activity with an IC50 of 0.012 nM. Tacrolimus inhibits CaN phosphatase in activated Jurkat cells with an IC50 of 0.18 nM.[2] In anti-CD3/CD2 system, tacrolimus inhibits Th1 cytokines (IL-2, IFN-γ), Th2 cytokines (IL-4, IL-5) and IL-3, GM-CSF (produced by both Th1 and Th2). Tacrolimus inhibits Th1 and Th2 cytokines with an IC50 ranging from 0.02 to 0.11 ng/mL. [3] Tacrolimus reduces the calcineurin (Cn) activity of T cells in vivo by the cumulative effects of several distinct mechanisms. [4] Tacrolimus can enhance experimentally induced irritant contact dermatitis and not to accelerate healing of irritant contact dermatitis and UVB erythema.[5]

Protocols

Tacrolimus is dissolved in ethanol at 1 or 0.5 mg/mL (alclometasone dipropionate) and further diluted in complete culture medium. [3]

References

[1] Panhans-Gross A, et al. Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506). J Allergy Clin Immunol. 2001, 107(2): 345-352. 閵嗏偓閵嗏偓
[2] Peterson LB, et al. A tacrolimus-related immunosuppressant with biochemical properties distinct from those of tacrolimus. Transplantation. 1998, 65(1): 10-18. 閵嗏偓閵嗏偓
[3] Sakuma S, et al. Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids). Int Immunopharmacol. 2001, 1(6): 1219-1226. 閵嗏偓閵嗏偓
[4] Suzuki N, et al. In vivo mechanisms for the inhibition of T lymphocyte activation by long-term therapy with tacrolimus (FK-506): experience in patients with Beh?et's disease. Arthritis Rheum. 1997, 40(6): 1157-1167. 閵嗏偓閵嗏偓
[5] Fuchs M, et al. Tacrolimus enhances irritation in a 5-day human irritancy in vivo model. Contact Dermatitis. 2002, 46(5): 290-294. 閵嗏偓閵嗏偓

Please click here to fill online order form, and we will make sure to supply you product with detail information. This process usually takes between 24 to 48 hours, depending on products stock avaliability. All inquires and subsequent projects are handled in the strictest confidence and will be backed by a confidentiality agreement if required.
KareBayTM provides scientists and clinicians with a wide range of biotechnological products and science lab supplies for chemical research and analyzing life processes. KareBay's extensive capabilities include commercializing reagents and kits, manufacturing biotech products and providing contract research services to organizations worldwide. Our many global labs, offices, and business partners enable KareBay to extend its products and services to its customer base around the world.

Our products are used for research, laboratory and further evaluation purposes. They are not for human use.